Transgene S.A.
TNG
Rang în acțiuni
#17525
Transgene SA, a French biotechnology firm headquartered in... Transgene SA, a French biotechnology firm headquartered in Illkirch-Graffenstaden, specializes in designing and developing groundbreaking therapeutic vaccines and oncolytic viruses to combat cancer and infectious diseases. Founded in 1979 and operating as a subsidiary of TSGH SAS, the company maintains a robust pipeline of treatments. This includes TG4050, a therapeutic vaccine in Phase I clinical trials for ovarian cancer and HPV-negative head and neck cancers, and TG4001, another therapeutic vaccine currently in Phase II for HPV-positive cancers. Its oncolytic virus programs feature TG6002, undergoing Phase I/IIa trials for various solid tumors, specifically gastrointestinal adenocarcinomas impacting the stomach, pancreas, and colon, as well as BT-001, an oncolytic virus in Phase I/II for solid tumors. Furthermore, Transgene is progressing TG1050, a therapeutic vaccine for chronic hepatitis B, and Pexa-Vec, an oncolytic virus targeting solid tumors. The company has established a comprehensive network of partnerships, encompassing strategic collaborations with major players like AstraZeneca, Merck KGaA, Pfizer, PersonGen BioTherapeutics, and NEC Corporation, alongside licensing agreements with SillaJen, Ascend BioPharmaceutical, and Valneva, and additional agreements with Sanofi, BioInvent, and Randox.
Preț acțiune
$0.81014398
Capitalizare de piață
$225.43M
Schimbare (1 zi)
-0.73%
Schimbare (1 an)
-46.14%
Țară
FR
Tranzacționează Transgene S.A. (TNG)
Categorie
Healthcare
Capitalizarea de piață a Transgene S.A.(TNG)
Capitalizare de piață: $225.43M
În anul October 2026, Transgene S.A. are o capitalizare de piață de $225.43M. Acest lucru face ca Transgene S.A. să fie a 17525th-a cea mai valoroasă companie din lume, conform datelor noastre. Capitalizarea bursieră reprezintă valoarea totală de piață a acțiunilor în circulație ale unei companii listate și este utilizată frecvent pentru a măsura valoarea unei companii.
Istoricul capitalizării de piață a Transgene S.A. din 2008 până în 2026
TNG în comparație cu top 5 cele mai populare stocks
| Prețul pentru TNG | Activul B | Capitalizarea de piață a B | Rezultate | |
|---|---|---|---|---|
$36,424.09
$116.99M
|
$5.252T | +4,489,329.13% | ||
|
$34,682.94
$116.99M
|
$5.001T | +4,274,724.21% | ||
|
$28,950.68
$116.99M
|
$4.175T | +3,568,198.68% | ||
|
$27,517.79
$116.99M
|
$3.968T | +3,391,588.45% | ||
|
$19,674.79
$116.99M
|
$2.837T | +2,424,903.86% |
